Author

Jan Hamouz

Observed names: Hamouz, Jan, J Hamouz

Institution: University Hospital Kralovske Vinohrady

Observed institutions: Charles University, University Hospital Kralovske Vinohrady, Comenius University Bratislava

OpenAlex ID: A5030164822

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial

2020 · Se Joon Woo, Miroslav Veith, et al. · JAMA Ophthalmology · 91

Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes

2021 · Neil M Bressler, Miroslav Veith, et al. · British Journal of Ophthalmology · 51

Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept

2019 · Justus G. Garweg, Jana Stefanickova, et al. · Ophthalmology Retina · 35

Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial

2022 · Justus G. Garweg, Jana Štefanickova, et al. · Advances in Therapy · 19

Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: Post Hoc Analysis of the PULSAR Randomized Clinical Trial

2025 · Won Ki Lee, Tien Y. Wong, et al. · JAMA Ophthalmology · 15

Randomized Trial of Biosimilar ABP 938 Compared with Reference Aflibercept in Adults with Neovascular Age-Related Macular Degeneration

2025 · Scott Friedman, Nikolas London, et al. · Ophthalmology Retina · 11

Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-Related Macular Degeneration

2024 · Jan Hamouz, Agnieszka Nowosielska, et al. · Ophthalmology Retina · 5

Contemporary Practices in Cataract Surgery- Subjective Preferences of Czech Cataract Surgeons

2022 · Pavel Studený, Jan Hamouz, et al. · Czech and Slovak Ophthalmology · 2

[Corneal transplantations in the Czech Republic in 2012].

2014 · P Studený, J Hamouz, et al. · PubMed · 2

[Autofluorescence as a diagnostic method].

2002 · T Sosna, J Hamouz · PubMed · 1

Effect of Key Baseline Disease Characteristics on Aflibercept 8 mg Dosing Interval Extension

2026 · Justus G. Garweg, Varun Chaudhary, et al. · Ophthalmology Retina

Infographic: Efficacy and Safety of High-Dose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the Phase 3 PULSAR Trial

2026 · Jean-François Korobelnik, Sergio Leal, et al. · Eye

2025 · Scott Friedman, Nikolas London, et al. · Ophthalmology Retina

[Standards in diagnosis and therapy: cataracts in adults].

2012 · P Kuchynka, Z Mazal, et al. · PubMed

Works count: 15

Citation count: 232

H-index: 6

I10-index: 6